An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.
Conclusion & alert: CVE-2023-33363 is rated Low Risk (38.5/100): CVSS High severity, with low exploitation likelihood (EPSS 0.08%). Mandatory action: Monitor for updates and reassess as exploit intelligence or EPSS changes.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2025-11-21 | 0.31% | 0.08% | -0.22% |
| 2 | 2025-11-18 | 0.08% | 0.31% | +0.22% |
| 3 | 2025-04-15 | — | 0.08% | — |
Full EPSS history (9 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 7.5 | 3.1 | HIGH |
|
3.9 | 3.6 | [email protected] |
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| supremainc | biostar_2 | < 2.9.1 | cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:* |
| URL | Tags |
|---|---|
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33363 | Third Party Advisory |
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | Release Notes Vendor Advisory |